The past year saw pipeline cuts and downsizing plans strike the biotech industry. Does the biotech job market seem to be looking up this year?| Labiotech.eu
Funding a biotech startup can be challenging. Delve into our guide to navigate this complicated investment landscape.| Labiotech.eu
Building a biotech startup can be a daunting task and often founders rely on incubators - but how to choose the right one?| Labiotech.eu
Here is a list of 14 biotech podcasts to keep you up to date with the latest advances in the biotechnology industry.| Labiotech.eu
The companies Candid Therapeutics, ArsenalBio, and eGenesis bagged the biggest private biotech investments in September 2024.| Labiotech.eu
The companies Treeline Biosciences, Kailera Therapeutics, and Seaport Therapeutics bagged the biggest private biotech investments in October 2024.| Labiotech.eu
The companies Uniquity Bio, AltruBio, and BridgeBio Oncology Therapeutics bagged the biggest private biotech investments in May 2024.| Labiotech.eu
The companies Formation Bio, Isotopen Technologien München, and Marea Therapeutics bagged the biggest private biotech investments in June 2024.| Labiotech.eu
The companies Xaira Therapeutics, Metsera, and Obsidian Therapeutics bagged the biggest private biotech investments in April 2024.| Labiotech.eu
Discover why some biotechs fail but survive with cash on hand, and how players like Concentra are trying to unlock trapped capital.| Labiotech.eu
Abivax, MapLight Therapeutics, Everest Medicines, and Soleno Therapeutics bagged the biggest biotech funding rounds overall in July 2025.| Labiotech.eu
Discover Denmark's dynamic biotech scene with 10 innovative companies at the forefront of the biopharmaceutical revolution!| Labiotech.eu
Learn how Deep Science Ventures’ zero-data approach tackles biotech’s early funding challenges to speed innovation and reduce risk.| Labiotech.eu
NATO Innovation Fund backs Portal Biotech in its first biotech move. What does this signal for strategic investment in healthcare innovation?| Labiotech.eu
XOMA Royalty’s acquisition of Turnstone Biologics highlights how royalty deals can revive biopharma companies and drive industry innovation.| Labiotech.eu
A spate of royalty deals are changing the way certain biotechs press ahead, as seen with Cytokinetics’ agreement with Royalty Pharma.| Labiotech.eu
The companies Metsera, Alentis Therapeutics, and Adcendo bagged the biggest private biotech investments in November 2024.| Labiotech.eu
The companies Cardurion Pharmaceuticals, Beacon Therapeutics, and Third Arc Bio bagged the biggest private biotech investments in July 2024.| Labiotech.eu
The companies Borealis Biosciences, Outpace Bio, and Halda Therapeutics bagged the biggest private biotech investments in August 2024.| Labiotech.eu
The companies Immunovant, Verdiva Bio, and Akero Therapeutics bagged the biggest biotech funding rounds overall in January 2025.| Labiotech.eu
The companies Nuvig Therapeutics, Ottimo Pharma, and Angitia Biopharmaceuticals bagged the biggest private biotech investments in December 2024.| Labiotech.eu
Take a look at six multiple sclerosis companies trying to make a difference to patients by advancing new treatments for the CNS disease.| Labiotech.eu
On its way to tackle cancer therapy resistance with its monoclonal antibody visugromab, CataLym completes a $150 million series D round.| Labiotech.eu
Explore five leading bioinformatics companies driving biopharma innovation in 2024 with advanced computer technology.| Labiotech.eu
The companies Mirador Therapeutics, Alumis, and Sionna Therapeutics bagged the biggest private biotech investments in March 2024.| Labiotech.eu